SYRS vs REGN: Which Stock is Better?

Side-by-side comparison of Syros Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

SYRS

Syros Pharmaceuticals Inc

$0.00

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricSYRSREGNWinner
Market Cap$0.01M$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth-0.0%0.0%REGN
Gross Margin-22863.0%44.6%REGN

Analyze SYRS

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SYRS or REGN a better investment?

Comparing SYRS and REGN: Syros Pharmaceuticals Inc has a market cap of $0.01M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SYRS and REGN?

SYRS (Syros Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SYRS or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: SYRS or REGN?

REGN has higher revenue growth at 0.0% vs -0.0% for SYRS.

Which company is more profitable: SYRS or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -22863.0% for SYRS.

Which is the larger company: SYRS or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $0.01M for SYRS.

Should I buy SYRS or REGN in 2026?

Both SYRS and REGN have investment merit. SYRS trades at $0.00 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SYRS and REGN stock?

Key differences: Market Cap ($0.01M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (-0.0% vs 0.0%), Gross Margin (-22863.0% vs 44.6%).

Popular Stock Comparisons